1. Orrego H, Blendis LM, Crossley IR, Medline A, Macdonald A, Ritchie S, et al. Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat. Gastroenterology 1981;80:546-556.
2. Blendis LM, Orrego H, Crossley IR, Blake JE, Medline A, Isreal Y. The role of hepatocyte enlargement in hepatic pressure in cirrhotic and noncirrhotic alcoholic liver disease. Hepatology 1982;2:539-546.
3. Grossman HJ, Grossman VL, Bhathal PS. The effect of hepatocyte enlargement on the hemodynamic characteristics of the isolated perfused rat liver preparation. Hepatology 1998;27:446-451.
4. Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1985;1:325-337.
5. Chao Y, Lin HC, Lee FY, Wang SS, Tsai YT, Hsia HC, et al. Hepatic hemodynamic features in patients with esophageal or gastric varices. J Hepatol 1993;19:85-89.
6. Hasumi A, Aoki H, Shimazu M, Kawata S, Yoshimatsu Y. Causative relationship between a hyperdynamic state due to increased A-V anastomoses in the gastric wall and AGML in patients with liver cirrhosis. J Gastroenterol Hepatol 1989;4 Suppl 1:143-145.
8. Iwase H, Kusugami K. Symposium on endoscopic hemostasis in gastric diseases. 2. Choice of endoscopic therapy for esophagogastric varices: aiming for safer and more effective therapy. Intern Med 1997;36:128-129.
9. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-231.
10. Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, et al. Survival in patients with Child-Pugh class C cirrhosis: analysis of the liver transplant registry in Japan. Hepatol Res 2017;47:1155-1164.
11. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996;11:51-58.
14. Kawanaka H, Ohta M, Hashizume M, Tomikawa M, Higashi H, Kishihara F, et al. Portosystemic encephalopathy treated with balloonoccluded retrograde transvenous obliteration. Am J Gastroenterol 1995;90:508-510.
16. Garcia-Pagán JC, Barrufet M, Cardenas A, Escorsell A. Management of gastric varices. Clin Gastroenterol Hepatol 2014;12:919-928 e1; quiz e51-e52.
18. Choi YS, Lee JH, Sinn DH, Song YB, Gwak GY, Choi MS, et al. Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices. J Clin Gastroenterol 2008;42:974-979.
19. Fukuda T, Hirota S, Sugimura K. Long-term results of balloonoccluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001;12:327-336.
21. Miyamoto Y, Oho K, Kumamoto M, Toyonaga A, Sata M. Balloonoccluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol 2003;18:934-942.
22. Akahane T, Iwasaki T, Kobayashi N, Tanabe N, Takahashi N, Gama H, et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 1997;92:1026-1030.
23. Uehara H, Akahoshi T, Tomikawa M, Kinjo N, Hashimoto N, Nagao Y, et al. Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient. J Gastroenterol Hepatol 2012;27:137-141.
24. Park SJ, Chung JW, Kim HC, Jae HJ, Park JH. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. J Vasc Interv Radiol 2010;21:503-507.
25. Arai H, Abe T, Takayama H, Toyoda M, Mori K, Ueno T, et al. Respiratory effects of balloon occluded retrograde transvenous obliteration of gastric varices: a prospective controlled study. J Gastroenterol Hepatol 2011;26:1389-1394.
27. Clements W, Cavanagh K, Ali F, Kavnoudias H, Kemp W, Roberts S, et al. Variant treatment for gastric varices with polidocanol foam using balloon-occluded retrograde transvenous obliteration: a pilot study. J Med Imaging Radiat Oncol 2012;56:599-605.
28. Yoshida H, Mamada Y, Taniai N, Yamamoto K, Kaneko M, Kawano Y, et al. Long-term results of partial splenic artery embolization as supplemental treatment for portal-systemic encephalopathy. Am J Gastroenterol 2005;100:43-47.